These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8073533)
1. Atherosclerosis in mice: getting to the heart of a polygenic disorder. Rubin EM; Smith DJ Trends Genet; 1994 Jun; 10(6):199-203. PubMed ID: 8073533 [TBL] [Abstract][Full Text] [Related]
5. New insights into atherosclerosis from studies with mouse models. Shih DM; Welch C; Lusis AJ Mol Med Today; 1995 Nov; 1(8):364-72. PubMed ID: 9415182 [TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis and the mouse: a decade of experience. Plump A Ann Med; 1997 Jun; 29(3):193-8. PubMed ID: 9240624 [TBL] [Abstract][Full Text] [Related]
7. New mouse models for lipoprotein metabolism and atherosclerosis. de Winther MP; Hofker MH Curr Opin Lipidol; 2002 Apr; 13(2):191-7. PubMed ID: 11891422 [TBL] [Abstract][Full Text] [Related]
8. Mouse models of hyperlipidemia and atherosclerosis. Fazio S; Linton MF Front Biosci; 2001 Mar; 6():D515-25. PubMed ID: 11229870 [TBL] [Abstract][Full Text] [Related]
9. [Value of transgenic mouse as model for the study of human lipoprotein metabolism]. Fournier N; Atger V; Paul JL; Moatti N Ann Biol Clin (Paris); 1995; 53(4):209-20. PubMed ID: 7574108 [TBL] [Abstract][Full Text] [Related]
10. Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Breslow JL Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8314-8. PubMed ID: 8378301 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E and the apolipoprotein E-deficient mouse. Plump AS; Breslow JL Annu Rev Nutr; 1995; 15():495-518. PubMed ID: 8527231 [TBL] [Abstract][Full Text] [Related]
12. Insights into lipoprotein metabolism from studies in transgenic mice. Breslow JL Annu Rev Physiol; 1994; 56():797-810. PubMed ID: 8010761 [No Abstract] [Full Text] [Related]
13. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Wouters K; Shiri-Sverdlov R; van Gorp PJ; van Bilsen M; Hofker MH Clin Chem Lab Med; 2005; 43(5):470-9. PubMed ID: 15899668 [TBL] [Abstract][Full Text] [Related]
14. Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Hofker MH; van Vlijmen BJ; Havekes LM Atherosclerosis; 1998 Mar; 137(1):1-11. PubMed ID: 9568731 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E-deficient mice created by systemic administration of antisense oligodeoxynucleotides: a new model for lipoprotein metabolism studies. Morishita R; Gibbons GH; Kaneda Y; Zhang L; Ogihara T; Dzau VJ J Endocrinol; 2002 Nov; 175(2):475-85. PubMed ID: 12429045 [TBL] [Abstract][Full Text] [Related]
19. Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer. Santamarina-Fojo S; Haudenschild C Int J Tissue React; 2000; 22(2-3):39-47. PubMed ID: 10937353 [TBL] [Abstract][Full Text] [Related]
20. An update on the hyperlipidemias and atherosclerosis. Powell RC Indiana Med; 1984 Jun; 77(6):441-5. PubMed ID: 6736617 [No Abstract] [Full Text] [Related] [Next] [New Search]